Diamorphine infusion in the preterm neonate.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 1590275)

Published in Arch Dis Child on October 01, 1991

Authors

A C Elias-Jones1, D A Barrett, N Rutter, P N Shaw, S S Davis

Author Affiliations

1: Department of Child Health, University Hospital, Queen's Medical Centre, Nottingham.

Articles by these authors

Effect of bronchodilators on respiratory resistance in infants and young children with bronchiolitis and wheezy bronchitis. Arch Dis Child (1975) 3.33

Making heel pricks less painful. Arch Dis Child (1983) 2.73

Role of routine investigations in children presenting with their first febrile convulsion. Arch Dis Child (1977) 2.42

Transit of pharmaceutical dosage forms through the small intestine. Gut (1986) 2.35

Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. Gastroenterology (1996) 2.13

PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release (1999) 2.08

Prediction of cerebral palsy in very low birthweight infants: prospective ultrasound study. Lancet (1987) 1.99

Exposure to invasive procedures in neonatal intensive care unit admissions. Arch Dis Child Fetal Neonatal Ed (1995) 1.87

Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev (2001) 1.87

Difficulties in diagnosing meningococcal meningitis in children. Br Med J (1979) 1.75

Barrier properties of the newborn infant's skin. J Pediatr (1983) 1.74

Periventricular leucomalacia and intraventricular haemorrhage in the preterm neonate. Arch Dis Child (1986) 1.71

Response of term babies to a warm environment. Arch Dis Child (1979) 1.70

Water loss from the skin of term and preterm babies. Arch Dis Child (1979) 1.64

Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res (1994) 1.61

Local anaesthetic effect of topical amethocaine gel in neonates: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed (2000) 1.56

Development of emotional sweating in the newborn infant. Arch Dis Child (1982) 1.55

Evaluation of impotence in older men. West J Med (1985) 1.54

The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res (1993) 1.53

Effect of night and day on preterm infants in a newborn nursery: randomised trial. Br Med J (Clin Res Ed) (1986) 1.51

Development of the epidermis in the newborn. Biol Neonate (1986) 1.51

Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun (1991) 1.50

Percutaneous carbon dioxide excretion in the newborn infant. Early Hum Dev (1990) 1.50

Percutaneous alcohol absorption and skin necrosis in a preterm infant. Arch Dis Child (1982) 1.47

Febrile convulsions--what do parents do? Br Med J (1978) 1.42

Nanoparticles in drug delivery. Crit Rev Ther Drug Carrier Syst (1987) 1.42

Heavy metals in some Asian medicines and cosmetics. Public Health (1979) 1.42

The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother (1997) 1.41

Optic nerve sheath decompression for glaucomatous optic neuropathy with normal intraocular pressure. Arch Ophthalmol (1993) 1.41

Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; Intralipid and Ivelip. J Clin Pharm Ther (1993) 1.40

Automated conductimetric titrimeter: use in studying ionic solute-solute interactions. J Pharm Sci (1975) 1.39

Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res (1994) 1.37

Calcium, magnesium, and glucose levels in blood and CSF of children with febrile convulsions. Arch Dis Child (1976) 1.31

Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm (1999) 1.30

Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res (1994) 1.30

Percutaneous administration of theophylline in the preterm infant. J Pediatr (1985) 1.29

Biodegradable microparticles as controlled release antigen delivery systems. Immunology (1991) 1.24

Reduction of head flattening in preterm infants. Arch Dis Child (1988) 1.22

Serum albumin concentrations and oedema in the newborn. Arch Dis Child (1986) 1.21

Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. Crit Rev Ther Drug Carrier Syst (1994) 1.21

Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res (1991) 1.20

Chitosan microspheres prepared by spray drying. Int J Pharm (1999) 1.20

Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J Control Release (2001) 1.20

Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology (1992) 1.19

Microparticles as potentially orally active immunological adjuvants. Vaccine (1989) 1.19

Clinical risk factors and periventricular leucomalacia. Arch Dis Child (1988) 1.19

A genetic nomenclature for human blood coagulation. Thromb Diath Haemorrh (1973) 1.18

The scars of newborn intensive care. Early Hum Dev (1990) 1.17

The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett (1992) 1.17

Visual loss from idiopathic intracranial pachymeningitis. Neurology (1994) 1.17

Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab (1990) 1.16

Reduction of skin water loss in the newborn. I. Effect of applying topical agents. Arch Dis Child (1981) 1.15

Incidence and prevalence of copper deficiency following roux-en-y gastric bypass surgery. Int J Obes (Lond) (2011) 1.14

Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation. Arch Dis Child (2004) 1.14

Compliance in medication by Asian immigrants. Nurs Times (1979) 1.13

The child with a non-blanching rash: how likely is meningococcal disease? Arch Dis Child (2001) 1.13

Lead poisoning and traditional practices: the consequences for world health. A study in Kuwait. Public Health (1981) 1.13

Transectional echo planar imaging of the heart in cyanotic congenital heart disease. Pediatr Radiol (1986) 1.12

Transport of nanoparticles across the rat nasal mucosa. J Drug Target (2001) 1.11

Humidification of incubators. Arch Dis Child (1985) 1.11

Morphine kinetics after diamorphine infusion in premature neonates. Br J Clin Pharmacol (1991) 1.09

Cardiac conduction disorders in six infants with "near-miss" sudden infant deaths. Br Med J (1977) 1.09

'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br J Pharmacol (2008) 1.09

Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res (1997) 1.08

Sweating in preterm babies. J Pediatr (1982) 1.08

Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta (1993) 1.08

Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target (1993) 1.07

Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance. J Drug Target (2001) 1.07

Antitumor benzothiazoles. 7. Synthesis of 2-(4-acylaminophenyl)benzothiazoles and investigations into the role of acetylation in the antitumor activities of the parent amines. J Med Chem (1999) 1.07

Lignocaine ointment and local anaesthesia in preterm infants. Arch Dis Child Fetal Neonatal Ed (1995) 1.06

Epi-fluorescence microscopy and image analysis used to measure diffusion coefficients in gel systems. J Pharm Pharmacol (1992) 1.06

Controlled release microparticles for vaccine development. Vaccine (1991) 1.06

Responses of the newborn infant to overheating. Biol Neonate (1983) 1.06

Defining the drug incorporation properties of PLA-PEG nanoparticles. Int J Pharm (2000) 1.06

Stress, severity of illness, and outcome in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed (1996) 1.05

Capillary blood sampling: should the heel be warmed? Arch Dis Child Fetal Neonatal Ed (1996) 1.05

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery. Vaccine (2000) 1.04

Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats. Eur J Neurosci (2008) 1.04

The role of gamma-scintigraphy in oral drug delivery. Adv Drug Deliv Rev (2001) 1.04

An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Biochim Biophys Acta (1993) 1.04

Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs. J Pharm Pharmacol (1984) 1.03

Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution. Pharm Res (1994) 1.02

Targeting of drugs and vaccines to the gut. Pharmacol Ther (1995) 1.02

Techniques for the measurement of the rheological properties of sputum. Bull Physiopathol Respir (Nancy) (1973) 1.02

Neurofibroma with aberrant tactile corpuscles. Acta Neuropathol (1974) 1.01

Heel blood sampling in preterm infants: which technique? Arch Dis Child Fetal Neonatal Ed (1994) 1.01

The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338). FEBS Lett (1984) 1.00

Intranasal delivery of morphine. J Pharmacol Exp Ther (2002) 0.99

The Arabidopsis thaliana/Myzus persicae model system demonstrates that a single gene can influence the interaction between a plant and a sap-feeding insect. Mol Ecol (2006) 0.99

Resistance to nonspecific protein adsorption by poly(vinyl alcohol) thin films adsorbed to a poly(styrene) support matrix studied using surface plasmon resonance. Anal Chem (2001) 0.99

Reduction of skin water loss in the newborn. II. Clinical trial of two methods in very low birthweight babies. Arch Dis Child (1981) 0.98

Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine (1995) 0.98

The heat balance of small babies nursed in incubators and under radiant warmers. Early Hum Dev (1982) 0.98

Increased incidence of paraproteinemia and autoantibodies in patients with normal-pressure glaucoma. Am J Ophthalmol (1994) 0.98

Structure and mucoadhesion of mussel glue protein in dilute solution. Biochemistry (1998) 0.98